Paul A Gleeson Selected Research

H(+)-K(+)-Exchanging ATPase (Hydrogen, Potassium ATPase)

7/2014	Helios defines T cells being driven to tolerance in the periphery and thymus.
6/2014	Transient systemic inflammation does not alter the induction of tolerance to gastric autoantigens by migratory dendritic cells.
1/2011	A convenient model of severe, high incidence autoimmune gastritis caused by polyclonal effector T cells and without perturbation of regulatory T cells.
8/2007	Prevention of autoimmune gastritis in mice requires extra-thymic T-cell deletion and suppression by regulatory T cells.
2/2006	CD4+CD25+ regulatory T cells inhibit the antigen-dependent expansion of self-reactive T cells in vivo.
10/2004	Growth factors associated with gastric mucosal hypertrophy in autoimmune gastritis.
10/2002	Immunopathogenesis, loss of T cell tolerance and genetics of autoimmune gastritis.
9/2002	Endogenous H/K ATPase beta-subunit promotes T cell tolerance to the immunodominant gastritogenic determinant.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paul A Gleeson Research Topics

Disease

12	Gastritis 01/2017 - 09/2002
6	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 09/2011
5	Autoimmune Diseases (Autoimmune Disease) 05/2013 - 10/2002
3	Inflammation (Inflammations) 01/2020 - 06/2014
3	Amyloid Plaque 01/2019 - 09/2011
2	Hypertrophy 01/2011 - 10/2004
1	Carcinogenesis 01/2021
1	Neuroinflammatory Diseases 01/2020
1	Hemophilia B (Haemophilia B) 01/2018
1	Neoplasm Metastasis (Metastasis) 11/2011
1	Neurodegenerative Diseases (Neurodegenerative Disease) 09/2011
1	Infections 06/2006
1	Hypertrophic Gastritis (Giant Hypertrophic Gastritis) 10/2004

Drug/Important Bio-Agent (IBA)

8	H(+)-K(+)-Exchanging ATPase (Hydrogen, Potassium ATPase)IBA 07/2014 - 09/2002
6	AutoantigensIBA 07/2014 - 10/2002
6	Adenosine Triphosphatases (ATPase)IBA 07/2014 - 10/2002
5	Amyloid (Amyloid Fibrils)IBA 01/2020 - 09/2011
4	Proteins (Proteins, Gene)FDA Link 01/2019 - 09/2013
4	Peptides (Polypeptides)IBA 01/2019 - 09/2011
3	AntigensIBA 01/2017 - 10/2008
2	CytokinesIBA 01/2020 - 06/2006
2	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 01/2016 - 09/2013
2	AutoantibodiesIBA 01/2011 - 10/2004
1	CholesterolIBA 01/2021
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2021
1	Amyloid beta-PeptidesIBA 01/2020
1	Factor IX (Coagulation Factor IX)FDA LinkGeneric 01/2018
1	AlbuminsIBA 01/2018
1	EnzymesIBA 01/2016
1	Peptide Hydrolases (Proteases)FDA Link 01/2016
1	DNA (Deoxyribonucleic Acid)IBA 06/2014
1	Immunosuppressive Agents (Immunosuppressants)IBA 05/2013
1	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2013
1	Proton Pumps (Proton Pump)IBA 11/2008
1	Polysaccharides (Glycans)IBA 10/2008
1	EpitopesIBA 10/2008
1	Membrane Proteins (Integral Membrane Proteins)IBA 11/2005
1	RNA (Ribonucleic Acid)IBA 10/2004
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2004
1	LigandsIBA 10/2004
1	GastrinsIBA 10/2004
1	ErbB Receptors (EGF Receptor)IBA 10/2004
1	Messenger RNA (mRNA)IBA 10/2004
1	AmphiregulinIBA 10/2004

Therapy/Procedure

1	Therapeutics 12/2006